NASDAQ:HCAT
Health Catalyst, Inc.
- Stock
Last Close
7.79
26/07 20:00
Market Cap
345.94M
Beta: 1.23
Volume Today
320.90K
Avg: 486.32K
PE Ratio
−4.42
PFCF: −12.46
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||
average payables | 1.32M - | 2.72M 105.44% | 4.48M 64.78% | 5.01M 11.96% | 4.56M 9.06% | 5.53M 21.37% | ||
average receivables | 22.37M - | 27.63M 23.50% | 37.93M 37.27% | 48.55M 27.98% | 48.39M 0.34% | 54.13M 11.87% | ||
book value per share | -9.34 - | -13.50 44.43% | 10.71 179.32% | 6.98 34.78% | 10.99 57.43% | 7.91 28.03% | 6.50 17.79% | |
capex per share | -0.12 - | -0.09 25.15% | -0.23 156.54% | -0.26 14.44% | -0.39 46.91% | -0.32 16.63% | -0.02 93.24% | |
capex to depreciation | -0.57 - | -0.34 40.50% | -0.47 39.32% | -0.56 18.79% | -0.49 11.95% | -0.36 26.73% | -0.04 89.45% | |
capex to operating cash flow | 0.09 - | 0.06 31.59% | 0.13 116.80% | 0.40 197.20% | 0.80 99.55% | 0.49 38.18% | 0.04 92.43% | |
capex to revenue | -0.05 - | -0.02 51.41% | -0.03 25.81% | -0.06 98.11% | -0.08 37.75% | -0.06 17.41% | -0.00 93.37% | |
cash per share | 1.85 - | 1.20 35.50% | 12.18 918.97% | 6.85 43.76% | 9.37 36.77% | 6.77 27.78% | 5.63 16.77% | |
days of inventory on hand | ||||||||
days payables outstanding | 6.97 - | 11.05 58.61% | 17.55 58.79% | 19.84 13.09% | 13.77 30.58% | 11.29 18.05% | 14.77 30.85% | |
days sales outstanding | 85.17 - | 89.80 5.43% | 64.95 27.67% | 93.35 43.73% | 73.63 21.12% | 63.38 13.91% | 74.36 17.32% | |
debt to assets | 0.11 - | 0.24 111.78% | 0.17 28.17% | 0.34 94.08% | 0.25 27.25% | 0.33 34.05% | 0.35 7.66% | |
debt to equity | -0.05 - | -0.07 47.57% | 0.26 465.57% | 0.71 169.49% | 0.39 44.59% | 0.58 48.88% | 0.68 16.34% | |
dividend yield | ||||||||
earnings yield | -0.04 - | -0.06 31.78% | -0.09 62.15% | -0.07 27.69% | -0.08 21.84% | -0.24 195.52% | -0.23 6.01% | |
enterprise value | 1.08B - | 1.09B 0.82% | 684.94M 36.94% | 1.82B 166.38% | 1.89B 3.76% | 702.73M 62.88% | 665.22M 5.34% | |
enterprise value over ebitda | -27.17 - | -20.84 23.31% | -15.00 28.00% | -23.57 57.12% | -17.84 24.32% | -7.66 57.05% | -10.01 30.62% | |
ev to operating cash flow | -29.25 - | -26.95 7.85% | -21.28 21.04% | -69.78 227.87% | -81.87 17.33% | -19.92 75.66% | -20.11 0.93% | |
ev to sales | 14.74 - | 9.65 34.55% | 4.42 54.18% | 9.66 118.56% | 7.83 19.01% | 2.54 67.49% | 2.25 11.64% | |
free cash flow per share | -1.45 - | -1.54 6.54% | -1.95 26.42% | -0.93 52.48% | -0.88 5.43% | -0.98 11.99% | -0.61 37.98% | |
free cash flow yield | -0.04 - | -0.04 6.54% | -0.06 42.70% | -0.02 62.12% | -0.02 3.90% | -0.09 317.41% | -0.07 28.80% | |
graham net net | -11.00 - | -15.55 41.34% | 7.86 150.52% | 0.14 98.24% | 3.61 2,520.11% | 1.34 62.80% | 0.50 63.00% | |
graham number | 18.87 - | 26.04 37.96% | 27.79 6.74% | 21.38 23.08% | 28.25 32.13% | 21.34 24.46% | 17.51 17.96% | |
income quality | 0.78 - | 0.65 16.97% | 0.54 17.62% | 0.23 57.55% | 0.15 33.61% | 0.26 70.08% | 0.28 9.08% | |
intangibles to total assets | 0.30 - | 0.29 4.40% | 0.10 66.47% | 0.36 270.18% | 0.33 7.73% | 0.37 11.98% | 0.38 1.74% | |
interest coverage | -31.00 - | -23.23 25.07% | -16.05 30.92% | -8.31 48.24% | -8.73 5.08% | -83.44 855.92% | -13.94 83.30% | |
interest debt per share | 0.51 - | 1.06 109.27% | 2.99 181.72% | 5.23 74.83% | 4.65 11.03% | 4.65 0.16% | 4.58 1.53% | |
inventory turnover | ||||||||
invested capital | -0.05 - | -0.07 47.57% | 0.26 465.57% | 0.71 169.49% | 0.39 44.59% | 0.58 48.88% | 0.68 16.34% | |
market cap | 1.09B - | 1.09B 0% | 650.31M 40.21% | 1.72B 164.68% | 1.88B 9.33% | 571.06M 69.65% | 522.43M 8.52% | |
net current asset value | -298.36M - | -418.88M 40.40% | 162.52M 138.80% | 28.16M 82.67% | 198.39M 604.57% | 100.52M 49.33% | 58.50M 41.80% | |
net debt to ebitda | 0.26 - | 0.03 88.80% | -0.76 2,692.34% | -1.34 76.01% | -0.11 91.96% | -1.44 1,238.33% | -2.15 49.65% | |
net income per share | -1.69 - | -2.23 31.78% | -3.21 43.65% | -2.91 9.29% | -3.23 10.90% | -2.56 20.71% | -2.09 18.12% | |
operating cash flow per share | -1.33 - | -1.45 9.41% | -1.72 18.33% | -0.66 61.49% | -0.49 26.38% | -0.66 34.85% | -0.59 10.69% | |
payables turnover | 52.39 - | 33.03 36.95% | 20.80 37.02% | 18.39 11.58% | 26.50 44.06% | 32.33 22.03% | 24.71 23.58% | |
receivables turnover | 4.29 - | 4.06 5.15% | 5.62 38.26% | 3.91 30.42% | 4.96 26.78% | 5.76 16.16% | 4.91 14.76% | |
research and ddevelopement to revenue | 0.39 - | 0.34 12.00% | 0.30 12.92% | 0.28 5.07% | 0.26 8.50% | 0.27 5.65% | 0.25 10.42% | |
return on tangible assets | -0.61 - | -0.78 28.50% | -0.22 71.97% | -0.31 40.90% | -0.27 11.33% | -0.29 5.42% | -0.27 6.88% | |
revenue per share | 2.63 - | 4.05 54.04% | 8.27 103.92% | 4.78 42.23% | 5.09 6.65% | 5.14 0.95% | 5.25 2.01% | |
roe | 0.18 - | 0.17 8.76% | -0.30 281.09% | -0.42 39.08% | -0.29 29.56% | -0.32 10.17% | -0.32 0.40% | |
roic | 0.19 - | 0.18 5.91% | -0.21 221.35% | -0.19 10.40% | -0.18 4.17% | -0.20 6.73% | -0.20 2.19% | |
sales general and administrative to revenue | 0.20 - | 0.20 0.22% | 0.20 1.55% | 0.31 53.26% | 0.36 13.23% | 0.22 37.12% | 0.26 15.82% | |
shareholders equity per share | -9.34 - | -13.50 44.43% | 10.71 179.32% | 6.98 34.78% | 10.99 57.43% | 7.91 28.03% | 6.50 17.79% | |
stock based compensation to revenue | 0.06 - | 0.04 35.74% | 0.12 208.83% | 0.20 74.53% | 0.27 33.97% | 0.26 3.07% | 0.19 27.82% | |
tangible asset value | -292.73M - | -406.77M 38.95% | 171.41M 142.14% | 69.36M 59.54% | 247.34M 256.62% | 146.84M 40.63% | 102.88M 29.93% | |
tangible book value per share | -10.54 - | -14.65 38.95% | 9.15 162.44% | 1.75 80.82% | 5.21 196.90% | 2.73 47.51% | 1.82 33.28% | |
working capital | 40.62M - | 25.05M 38.32% | 216.02M 762.29% | 241.76M 11.92% | 415.34M 71.80% | 345.29M 16.87% | 304.36M 11.85% |
All numbers in USD (except ratios and percentages)